AU2002241576A1 - Paramagnetic metal ion-based macrocyclic contrast agents - Google Patents
Paramagnetic metal ion-based macrocyclic contrast agentsInfo
- Publication number
- AU2002241576A1 AU2002241576A1 AU2002241576A AU4157602A AU2002241576A1 AU 2002241576 A1 AU2002241576 A1 AU 2002241576A1 AU 2002241576 A AU2002241576 A AU 2002241576A AU 4157602 A AU4157602 A AU 4157602A AU 2002241576 A1 AU2002241576 A1 AU 2002241576A1
- Authority
- AU
- Australia
- Prior art keywords
- metal ion
- contrast agents
- paramagnetic metal
- based macrocyclic
- macrocyclic contrast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002872 contrast media Substances 0.000 title 1
- 229910021645 metal ion Inorganic materials 0.000 title 1
- 230000005298 paramagnetic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25226900P | 2000-11-20 | 2000-11-20 | |
| US60/252,269 | 2000-11-20 | ||
| PCT/US2001/046151 WO2002043775A2 (en) | 2000-11-20 | 2001-11-20 | Paramagnetic metal ion-based macrocyclic contrast agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002241576A1 true AU2002241576A1 (en) | 2002-06-11 |
Family
ID=22955292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002241576A Abandoned AU2002241576A1 (en) | 2000-11-20 | 2001-11-20 | Paramagnetic metal ion-based macrocyclic contrast agents |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US6875419B2 (en) |
| EP (1) | EP1390079A2 (en) |
| AU (1) | AU2002241576A1 (en) |
| WO (1) | WO2002043775A2 (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7632651B2 (en) | 1997-09-15 | 2009-12-15 | Mds Analytical Technologies (Us) Inc. | Molecular modification assays |
| EP2025350A3 (en) * | 1999-04-21 | 2009-12-09 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Determining pH by CEDST MRI |
| US7067111B1 (en) | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| WO2001091807A2 (en) | 2000-06-02 | 2001-12-06 | Board Of Regents | Ethylenedicysteine (ec)-drug conjugates |
| WO2002043775A2 (en) * | 2000-11-20 | 2002-06-06 | GODFREY, Cullen, M. | Paramagnetic metal ion-based macrocyclic contrast agents |
| JP4731117B2 (en) | 2002-01-24 | 2011-07-20 | バーンズ−ジューイッシュ ホスピタル | Integrin targeted imaging agents |
| EP1331012A1 (en) | 2002-01-29 | 2003-07-30 | BRACCO IMAGING S.p.A. | Responsive paramagnetic MRI contrast agents |
| EP1466629A1 (en) * | 2003-04-11 | 2004-10-13 | BRACCO IMAGING S.p.A. | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications |
| AU2004263136A1 (en) * | 2003-08-08 | 2005-02-17 | Barnes-Jewish Hospital | Emulsion particles for imaging and therapy and methods of use thereof |
| US9050378B2 (en) | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
| US7504088B2 (en) | 2004-06-09 | 2009-03-17 | Kereos, Inc. | Lipophilic derivatives of chelate monoamides |
| EP1793868B1 (en) * | 2004-09-23 | 2010-12-29 | Guerbet | Liposomal contrast agents for cest imaging |
| CA2581639C (en) | 2004-09-30 | 2016-07-26 | Molecular Devices Corporation | Luminescent lanthanide complexes |
| EP1877813B1 (en) | 2005-04-26 | 2013-06-19 | Koninklijke Philips Electronics N.V. | Mri involving contrast agent with time modulated contrast enhancement |
| US7917188B2 (en) * | 2005-04-26 | 2011-03-29 | Koninklijke Philips Electronics N.V. | Method for using CEST contrast agents in MRI |
| DE602006008604D1 (en) * | 2005-04-26 | 2009-10-01 | Koninkl Philips Electronics Nv | CONTRASTING AGENTS FOR MAGNETIC RESONANCE IMAGING WITH CEST-ACTIVE PARAMAGNETIC COMPLEX |
| US20060275217A1 (en) * | 2005-05-06 | 2006-12-07 | Caravan Peter D | Chemical exchange saturation transfer contrast agents |
| US7330028B2 (en) * | 2005-09-26 | 2008-02-12 | General Electric Company | Apparatus and method of simultaneous fat suppression, magnetization transfer contrast, and spatial saturation for 3D time-of-flight imaging |
| US8003078B2 (en) * | 2006-03-29 | 2011-08-23 | Barnes-Jewish Hospital | Targeted MR imaging agents |
| EP2019667A4 (en) * | 2006-04-27 | 2012-08-22 | Barnes Jewish Hospital | IDENTIFICATION AND IMAGING OF TARGET TISSUE |
| US20090142273A1 (en) * | 2006-06-08 | 2009-06-04 | Case Western Reserve University | Activatable cest MRI agent |
| US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| EP2205986B1 (en) * | 2007-09-26 | 2013-07-03 | The Johns Hopkins University | Frequency referencing for chemical exchange saturation transfer (cest) mri |
| EP2457594A1 (en) * | 2010-11-05 | 2012-05-30 | Bracco Imaging S.p.A | Cest systems exhibiting a concentration independent responsiveness |
| US9302019B2 (en) * | 2011-05-11 | 2016-04-05 | The Research Foundation For The State University Of New York | Fe(II) sequestering agents and uses thereof |
| WO2015142583A1 (en) | 2014-03-17 | 2015-09-24 | The Board Of Regents Of The University Of Texas System | New gadolinium-based contrast agents for sensitive detection of zn2+ with mri |
| KR102668430B1 (en) * | 2022-11-29 | 2024-05-24 | 재단법인 대구경북첨단의료산업진흥재단 | New glutathione-sensitive compound and medical use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5316757A (en) | 1984-10-18 | 1994-05-31 | Board Of Regents, The University Of Texas System | Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups |
| MX174467B (en) | 1986-01-23 | 1994-05-17 | Squibb & Sons Inc | 1,4,7-TRISCARBOXIMETHYL-1,4,7,10-TETRAAZACICLODO DECAN SUBSTITUTE IN 1 AND ANALOG COMPOUNDS |
| US5050609B1 (en) | 1987-10-04 | 1999-11-02 | Us Health | Magnetization transfer contrast and proton relaxation and use thereof in magnetic resonance imaging |
| US5914095A (en) | 1989-04-07 | 1999-06-22 | Salutar, Inc. | Polychelants containg amide bonds |
| EP0489869B1 (en) * | 1989-08-28 | 1998-11-11 | The General Hospital Corporation | Hydroxy-aryl metal chelates for diagnostic nmr imaging |
| ATE199550T1 (en) | 1993-12-30 | 2001-03-15 | Guerbet Sa | POLYAMINATED LIGANDS, METAL COMPLEXES, METHOD OF PREPARATION AND DIAGNOSTIC AND THERAPEUTIC USES |
| IT1291624B1 (en) | 1997-04-18 | 1999-01-11 | Bracco Spa | COMPLEX CHELATES OF PARAMAGNETIC METALS WITH LOW TOXICITY |
| AU3225900A (en) * | 1999-02-09 | 2000-08-29 | Board Of Regents, The University Of Texas System | Ph sensitive mri contrast agents |
| EP2025350A3 (en) | 1999-04-21 | 2009-12-09 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Determining pH by CEDST MRI |
| WO2002043775A2 (en) * | 2000-11-20 | 2002-06-06 | GODFREY, Cullen, M. | Paramagnetic metal ion-based macrocyclic contrast agents |
-
2001
- 2001-11-20 WO PCT/US2001/046151 patent/WO2002043775A2/en not_active Ceased
- 2001-11-20 US US10/001,858 patent/US6875419B2/en not_active Expired - Fee Related
- 2001-11-20 AU AU2002241576A patent/AU2002241576A1/en not_active Abandoned
- 2001-11-20 EP EP01988253A patent/EP1390079A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US6875419B2 (en) | 2005-04-05 |
| WO2002043775A3 (en) | 2003-12-18 |
| EP1390079A2 (en) | 2004-02-25 |
| WO2002043775A2 (en) | 2002-06-06 |
| US20020127182A1 (en) | 2002-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002241576A1 (en) | Paramagnetic metal ion-based macrocyclic contrast agents | |
| AU2002225701A1 (en) | Integrated magnetic bearing | |
| AU6777701A (en) | Service-oriented community agent | |
| GB2387822B (en) | Axle | |
| GB2381456B (en) | An anhydrofructose derived antimicrobial agent | |
| AU2002323180A1 (en) | Hydroxypyridonate and hydroxypyrimidinone chelating agents | |
| AU2002214284A1 (en) | Anti-helicobacterial agents | |
| AU2001276956A1 (en) | Macrocyclic mri contrast agents | |
| AU2002256602A1 (en) | Paramagnetic nanoparticle | |
| AU143621S (en) | Time piece | |
| EP1151667A3 (en) | Plant-activating agent | |
| HUP0302350A3 (en) | Co-mn-fe soft magnetic alloys | |
| AU144168S (en) | An iron | |
| GB2363716B (en) | Arthropod-controlling pyrones | |
| AU2001291629A1 (en) | Foundry rolling unit | |
| EP1291461A4 (en) | Color-recovering agent | |
| AU7079601A (en) | Magnetic bearings | |
| AU2001293749A1 (en) | Magnetic component | |
| AU2001274683A1 (en) | Contrast agents | |
| GB2360495B (en) | Wheelbarrow aid | |
| GB0010839D0 (en) | Biostatic agent | |
| GB0021921D0 (en) | Kit of adhesion-release agents | |
| GB0004155D0 (en) | Metal reduction | |
| AU2001277537A1 (en) | Agents | |
| GB0025070D0 (en) | Contrast agents |